Protein & Cell

, Volume 1, Issue 1, pp 22–32 | Cite as

Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene

Review

Abstract

Telomerase expression and telomere maintenance are critical for long-term cell proliferation and survival, and they play important roles in development, aging, and cancer. Cumulating evidence has indicated that regulation of the rate-limiting subunit of human telomerase reverse transcriptase gene (hTERT) is a complex process in normal cells and many cancer cells. In addition to a number of transcriptional activators and repressors, the chromatin environment and epigenetic status of the endogenous hTERT locus are also pivotal for its regulation in normal human somatic cells and in tumorigenesis.

Keywords

telomerase transcriptional regulation chromatin epigenetic regulation cancer 

References

  1. Aisner, D.L., Wright, W.E., and Shay, J.W. (2002). Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev 12, 80–85.PubMedGoogle Scholar
  2. Akiyama, M., Hideshima, T., Hayashi, T., Tai, Y.T., Mitsiades, C.S., Mitsiades, N., Chauhan, D., Richardson, P., Munshi, N.C., and Anderson, K.C. (2003). Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63, 18–21.PubMedGoogle Scholar
  3. Atkinson, S.P., Hoare, S.F., Glasspool, R.M., and Keith, W.N. (2005). Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65, 7585–7590.PubMedGoogle Scholar
  4. Bazarov, A.V., Hines, W.C., Mukhopadhyay, R., Beliveau, A., Melodyev, S., Zaslavsky, Y., and Yaswen, P. (2009). Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes. Cell Cycle 8, 3373–3378.PubMedGoogle Scholar
  5. Blackburn, E.H., Chan, S., Chang, J., Fulton, T.B., Krauskopf, A., McEachern, M., Prescott, J., Roy, J., Smith, C., and Wang, H. (2000). Molecular manifestations and molecular determinants of telomere capping. Cold Spring Harb Symp Quant Biol 65, 253–263.PubMedGoogle Scholar
  6. Blasco, M.A., Funk, W., Villeponteau, B., and Greider, C.W. (1995). Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267–1270.PubMedGoogle Scholar
  7. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [see comments]. Cell 91, 25–34.PubMedGoogle Scholar
  8. Blasco, M.A., Rizen, M., Greider, C.W., and Hanahan, D. (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genetics 12, 200–204.PubMedGoogle Scholar
  9. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells [see comments]. Science 279, 349–352.PubMedGoogle Scholar
  10. Cao, Y., Bryan, T.M., and Reddel, R.R. (2008). Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 99, 1092–1099.PubMedGoogle Scholar
  11. Cassar, L., Li, H., Pinto, A.R., Nicholls, C., Bayne, S., and Liu, J.P. (2008). Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res 68, 9157–9166.PubMedGoogle Scholar
  12. Chatagnon, A., Bougel, S., Perriaud, L., Lachuer, J., Benhattar, J., and Dante, R. (2009). Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells. Carcinogenesis 30, 28–34.PubMedGoogle Scholar
  13. Chiu, C.P., Dragowska, W., Kim, N.W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C.B., and Lansdorp, P.M. (1996). Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14, 239–248.PubMedGoogle Scholar
  14. Cohen, S.B., Graham, M.E., Lovrecz, G.O., Bache, N., Robinson, P. J., and Reddel, R.R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850–1853.PubMedGoogle Scholar
  15. Collins, K. (2000). Mammalian telomeres and telomerase. Current Opinion in Cell Biology 12, 378–383.PubMedGoogle Scholar
  16. Cong, Y.S., and Bacchetti, S. (2000). Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem 275, 35665–35668.PubMedGoogle Scholar
  17. Cong, Y.S., Wen, J., and Bacchetti, S. (1999). The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8, 137–142.PubMedGoogle Scholar
  18. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B., and Bacchetti, S. (1994). Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68, 3410–3414.PubMedPubMedCentralGoogle Scholar
  19. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R. L., Lansdorp, P.M., Sedivy, J.M., and Weinberg, R.A. (1998). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A 95, 14723–14728.PubMedPubMedCentralGoogle Scholar
  20. Crowe, D.L., Nguyen, D.C., Tsang, K.J., and Kyo, S. (2001). E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res 29, 2789–2794.PubMedPubMedCentralGoogle Scholar
  21. de la Serna, I.L., Ohkawa, Y., and Imbalzano, A.N. (2006). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7, 461–473.PubMedGoogle Scholar
  22. Dessain, S.K., Yu, H., Reddel, R.R., Beijersbergen, R.L., and Weinberg, R.A. (2000). Methylation of the human telomerase gene CpG island. Cancer Res 60, 537–541.PubMedGoogle Scholar
  23. Devereux, T.R., Horikawa, I., Anna, C.H., Annab, L.A., Afshari, C.A., and Barrett, J.C. (1999). DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59, 6087–6090.PubMedGoogle Scholar
  24. Ducrest, A.L., Amacker, M., Mathieu, Y.D., Cuthbert, A.P., Trott, D.A., Newbold, R.F., Nabholz, M., and Lingner, J. (2001). Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res 61, 7594–7602.PubMedGoogle Scholar
  25. Ducrest, A.L., Szutorisz, H., Lingner, J., and Nabholz, M. (2002). Regulation of the human telomerase reverse transcriptase gene. Oncogene 21, 541–552.PubMedGoogle Scholar
  26. Dwyer, J., Li, H., Xu, D., and Liu, J.P. (2007). Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann N Y Acad Sci 1114, 36–47.PubMedGoogle Scholar
  27. Ferber, M.J., Montoya, D.P., Yu, C., Aderca, I., McGee, A., Thorland, E.C., Nagorney, D.M., Gostout, B.S., Burgart, L.J., Boix, L., et al. (2003). Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 22, 3813–3820.PubMedGoogle Scholar
  28. Forsyth, N.R., Elder, F.F., Shay, J.W., and Wright, W.E. (2005). Lagomorphs (rabbits, pikas and hares) do not use telomere-directed replicative aging in vitro. Mech Ageing Dev 126, 685–691.PubMedGoogle Scholar
  29. Fujimoto, K., Kyo, S., Takakura, M., Kanaya, T., Kitagawa, Y., Itoh, H., Takahashi, M., and Inoue, M. (2000). Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res 28, 2557–2562.PubMedPubMedCentralGoogle Scholar
  30. Günes, C., Lichtsteiner, S., Vasserot, A.P., and Englert, C. (2000). Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60, 2116–2121.PubMedGoogle Scholar
  31. Ge, Z., Li, W., Wang, N., Liu, C., Zhu, Q., Bjorkholm, M., Gruber, A., and Xu, D. (2009). Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. Faseb J. In press.Google Scholar
  32. Ge, Z., Liu, C., Bjorkholm, M., Gruber, A., and Xu, D. (2006). Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation. Mol Cell Biol 26, 230–237.PubMedPubMedCentralGoogle Scholar
  33. Goueli, B.S., and Janknecht, R. (2004). Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol 24, 25–35.PubMedPubMedCentralGoogle Scholar
  34. Greenberg, R.A. (2005). Telomeres, crisis and cancer. Curr Mol Med 5, 213–218.PubMedGoogle Scholar
  35. Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B., and DePinho, R.A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723–1730.PubMedGoogle Scholar
  36. Greenberg, R.A., O’Hagan, R.C., Deng, H., Xiao, Q., Hann, S.R., Adams, R.R., Lichtsteiner, S., Chin, L., Morin, G.B., and DePinho, R.A. (1999). Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219–1226.PubMedGoogle Scholar
  37. Guilleret, I., and Benhattar, J. (2003). Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 289, 326–334.PubMedGoogle Scholar
  38. Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F.T., and Benhattar, J. (2002). Int J Cancer 101, 335–341.PubMedGoogle Scholar
  39. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., and Weinberg, R.A. (1999a). Creation of human tumour cells with defined genetic elements [see comments]. Nature 400, 464–468.PubMedGoogle Scholar
  40. Hahn, W.C., Stewart, S.A., Brooks, M.W., York, S.G., Eaton, E., Kurachi, A., Beijersbergen, R.L., Knoll, J.H., Meyerson, M., and Weinberg, R.A. (1999b). Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5, 1164–1170.PubMedGoogle Scholar
  41. Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Bass, M.B., Arruda, I., and Robinson, M.O. (1997). A mammalian telomerase-associated protein [see comments]. Science 275, 973–977.PubMedGoogle Scholar
  42. Horikawa, I., Cable, P.L., Afshari, C., and Barrett, J.C. (1999). Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59, 826–830.PubMedGoogle Scholar
  43. Horikawa, I., Cable, P.L., Mazur, S.J., Appella, E., Afshari, C.A., and Barrett, J.C. (2002). Downstream E-Box-mediated Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Transcription: Evidence for an Endogenous Mechanism of Transcriptional Repression. Mol Biol Cell 13, 2585–2597.PubMedPubMedCentralGoogle Scholar
  44. Horikawa, I., Chiang, Y.J., Patterson, T., Feigenbaum, L., Leem, S.H., Michishita, E., Larionov, V., Hodes, R.J., and Barrett, J.C. (2005). Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element. Proc Natl Acad Sci U S A 102, 18437–18442.PubMedPubMedCentralGoogle Scholar
  45. Horikawa, I., Oshimura, M., and Barrett, J.C. (1998). Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 22, 65–72.PubMedGoogle Scholar
  46. Hornsby, P.J. (2007). Senescence as an anticancer mechanism. J Clin Oncol 25, 1852–1857.PubMedGoogle Scholar
  47. Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Bjorkholm, M., Henriksson, M., Gruber, A., et al. (2002). The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res 274, 25–34.PubMedGoogle Scholar
  48. Janknecht, R. (2004). On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 564, 9–13.PubMedGoogle Scholar
  49. Jenuwein, T., and Allis, C.D. (2001). Translating the histone code.[see comment]. Science 293, 1074–1080.PubMedGoogle Scholar
  50. Kaeser, M.D., and Emerson, B.M. (2006). Remodeling plans for cellular specialization: unique styles for every room. Curr Opin Genet Dev 16, 508–512.PubMedGoogle Scholar
  51. Kang, S.S., Kwon, T., Kwon, D.Y., and Do, S.I. (1999). Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274, 13085–13090.PubMedGoogle Scholar
  52. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer [see comments]. Science 266, 2011–2015.PubMedGoogle Scholar
  53. Klingelhutz, A.J., Foster, S.A., and McDougall, J.K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79–82.PubMedGoogle Scholar
  54. Kyo, S., Takakura, M., Fujiwara, T., and Inoue, M. (2008). Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99, 1528–1538.PubMedGoogle Scholar
  55. Kyo, S., Takakura, M., Kanaya, T., Zhuo, W., Fujimoto, K., Nishio, Y., Orimo, A., and Inoue, M. (1999). Estrogen activates telomerase. Cancer Res 59, 5917–5921.PubMedGoogle Scholar
  56. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M. (2000). Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28, 669–677.PubMedPubMedCentralGoogle Scholar
  57. Li, H., and Liu, J.P. (2007). Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann N Y Acad Sci 1114, 56–68.PubMedGoogle Scholar
  58. Li, H., Xu, D., Li, J., Berndt, M.C., and Liu, J.P. (2006). Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J Biol Chem 281, 25588–25600.PubMedGoogle Scholar
  59. Lin, S.Y., and Elledge, S.J. (2003). Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881–889.PubMedGoogle Scholar
  60. Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T.R. (1997). Reverse transcriptase motifs in the catalytic subunit of telomerase [see comments]. Science 276, 561–567.PubMedGoogle Scholar
  61. Liu, C., Fang, X., Ge, Z., Jalink, M., Kyo, S., Bjorkholm, M., Gruber, A., Sjoberg, J., and Xu, D. (2007). The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res 67, 2626–2631.PubMedGoogle Scholar
  62. Liu, L., Lai, S., Andrews, L.G., and Tollefsbol, T.O. (2004). Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340, 1–10.PubMedGoogle Scholar
  63. Martin-Rivera, L., Herrera, E., Albar, J.P., and Blasco, M.A. (1998). Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci U S A 95, 10471–10476.PubMedPubMedCentralGoogle Scholar
  64. Maser, R.S., DePinho, R.A., and Masera, G. (2002). Connecting chromosomes, crisis, and cancer. Science 297, 565–569.PubMedGoogle Scholar
  65. Masutomi, K., Yu, E.Y., Khurts, S., Ben-Porath, I., Currier, J.L., Metz, G.B., Brooks, M.W., Kaneko, S., Murakami, S., DeCaprio, J.A., et al. (2003). Telomerase maintains telomere structure in normal human cells. Cell 114, 241–253.PubMedGoogle Scholar
  66. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785–795.PubMedGoogle Scholar
  67. Morin, G.B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521–529.PubMedGoogle Scholar
  68. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B., and Cech, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human [see comments]. Science 277, 955–959.PubMedGoogle Scholar
  69. Nash, S.R., Giros, B., Kingsmore, S.F., Kim, K.M., el-Mestikawy, S., Dong, Q., Fumagalli, F., Seldin, M.F., and Caron, M.G. (1998). Cloning, gene structure and genomic localization of an orphan transporter from mouse kidney with six alternatively-spliced isoforms. Receptors Channels 6, 113–128.PubMedGoogle Scholar
  70. Oh, S., Song, Y., Yim, J., and Kim, T.K. (1999). The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 274, 37473–37478.PubMedGoogle Scholar
  71. Palmqvist, R., Zhang, A., Xu, D., Golovleva, I., Norrback, K.F., Gruber, A., Oberg, A., Stenling, R., and Roos, G. (2005). hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer. Int J Cancer 116, 395–400.PubMedGoogle Scholar
  72. Pirker, C., Holzmann, K., Spiegl-Kreinecker, S., Elbling, L., Thallinger, C., Pehamberger, H., Micksche, M., and Berger, W. (2003). Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res 13, 483–492.PubMedGoogle Scholar
  73. Prowse, K.R., and Greider, C.W. (1995). Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A 92, 4818–4822.PubMedPubMedCentralGoogle Scholar
  74. Renaud, S., Bosman, F.T., and Benhattar, J. (2003). Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. Biochem Biophys Res Commun 300, 47–54.PubMedGoogle Scholar
  75. Renaud, S., Loukinov, D., Bosman, F.T., Lobanenkov, V., and Benhattar, J. (2005). CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res 33, 6850–6860.PubMedPubMedCentralGoogle Scholar
  76. Ritz, J.M., Kuhle, O., Riethdorf, S., Sipos, B., Deppert, W., Englert, C., and Gunes, C. (2005). A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues. Cancer Res 65, 1187–1196.PubMedGoogle Scholar
  77. Rudolph, K.L., Chang, S., Lee, H.W., Blasco, M., Gottlieb, G.J., Greider, C., and DePinho, R.A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712.PubMedGoogle Scholar
  78. Shay, J.W., and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33, 787–791.PubMedGoogle Scholar
  79. Shay, J.W., and Wright, W.E. (1989). Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184, 109–118.PubMedGoogle Scholar
  80. Shippen-Lentz, D., and Blackburn, E.H. (1990). Functional evidence for an RNA template in telomerase. Science 247, 546–552.PubMedGoogle Scholar
  81. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors.[see comment]. Cell 131, 861–872.PubMedGoogle Scholar
  82. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.[see comment]. Cell 126, 663–676.PubMedGoogle Scholar
  83. Takakura, M., Kyo, S., Inoue, M., Wright, W.E., and Shay, J.W. (2005). Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 25, 8037–8043.PubMedPubMedCentralGoogle Scholar
  84. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. (1999). Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59, 551–557.PubMedGoogle Scholar
  85. Takakura, M., Kyo, S., Sowa, Y., Wang, Z., Yatabe, N., Maida, Y., Tanaka, M., and Inoue, M. (2001). Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29, 3006–3011.PubMedPubMedCentralGoogle Scholar
  86. Takuma, Y., Nouso, K., Kobayashi, Y., Nakamura, S., Tanaka, H., Matsumoto, E., Fujikawa, T., Suzuki, M., Hanafusa, T., and Shiratori, Y. (2004). Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. J Gastroenterol Hepatol 19, 1300–1304.PubMedGoogle Scholar
  87. Veldman, T., Liu, X., Yuan, H., and Schlegel, R. (2003). Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci U S A 100, 8211–8216.PubMedPubMedCentralGoogle Scholar
  88. Venteicher, A.S., Abreu, E.B., Meng, Z., McCann, K.E., Terns, R.M., Veenstra, T.D., Terns, M.P., and Artandi, S.E. (2009). A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323, 644–648.PubMedPubMedCentralGoogle Scholar
  89. Wang, J., Xie, L.Y., Allan, S., Beach, D., and Hannon, G.J. (1998). Myc activates telomerase. Genes Dev 12, 1769–1774.PubMedPubMedCentralGoogle Scholar
  90. Wang, S., Hu, C., and Zhu, J. (2007). Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell 18, 669–677.PubMedPubMedCentralGoogle Scholar
  91. Wang, S., Robertson, G.P., and Zhu, J. (2004). A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers. Gene 343, 69–78.PubMedGoogle Scholar
  92. Wang, S., Zhao, Y., Hu, C., and Zhu, J. (2009). Differential repression of human and mouse TERT genes during cell differentiation. Nucleic Acids Res 37, 2618–2629.PubMedPubMedCentralGoogle Scholar
  93. Wang, S., and Zhu, J. (2003). Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J Biol Chem 278, 18842–18850.PubMedGoogle Scholar
  94. Wang, S., and Zhu, J. (2004). The hTERT gene is embedded in a nuclease-resistant chromatin domain. J Biol Chem 279, 55401–55410.PubMedGoogle Scholar
  95. Weng, N.P., Levine, B.L., June, C.H., and Hodes, R.J. (1996). Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183, 2471–2479.PubMedGoogle Scholar
  96. Wernig, M., Meissner, A., Cassady, J.P., and Jaenisch, R. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12.PubMedGoogle Scholar
  97. Wick, M., Zubov, D., and Hagen, G. (1999). Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232, 97–106.PubMedGoogle Scholar
  98. Won, J., Yim, J., and Kim, T.K. (2002). Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells. J Biol Chem 277, 38230–38238.PubMedGoogle Scholar
  99. Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W., and Shay, J.W. (1996). Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18, 173–179.PubMedGoogle Scholar
  100. Wu, K.J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. (1999). Direct activation of TERT transcription by c-MYC. Nat Genet 21, 220–224.PubMedGoogle Scholar
  101. Xu, D., Dwyer, J., Li, H., Duan, W., and Liu, J.P. (2008a). Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J Biol Chem 283, 23567–23580.PubMedPubMedCentralGoogle Scholar
  102. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A.R., and Henriksson, M. (2001). Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 98, 3826–3831.PubMedPubMedCentralGoogle Scholar
  103. Xu, M., Luo, W., Elzi, D.J., Grandori, C., and Galloway, D.A. (2008b). NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes. Mol Cell Biol 28, 4819–4828.PubMedPubMedCentralGoogle Scholar
  104. Yasumoto, S., Kunimura, C., Kikuchi, K., Tahara, H., Ohji, H., Yamamoto, H., Ide, T., and Utakoji, T. (1996). Telomerase activity in normal human epithelial cells. Oncogene 13, 433–439.PubMedGoogle Scholar
  105. Yaswen, P., and Stampfer, M.R. (2002). Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol 34, 1382–1394.PubMedGoogle Scholar
  106. Yi, X., Shay, J.W., and Wright, W.E. (2001). Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29, 4818–4825.PubMedPubMedCentralGoogle Scholar
  107. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920.PubMedGoogle Scholar
  108. Zhang, A., Zheng, C., Hou, M., Lindvall, C., Wallin, K.L., Angstrom, T., Yang, X., Hellstrom, A.C., Blennow, E., Bjorkholm, M., et al. (2002). Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer 34, 269–275.PubMedGoogle Scholar
  109. Zhang, A., Zheng, C., Lindvall, C., Hou, M., Ekedahl, J., Lewensohn, R., Yan, Z., Yang, X., Henriksson, M., Blennow, E., et al. (2000). Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 60, 6230–6235.PubMedGoogle Scholar
  110. Zhang, Z., and Reese, J.C. (2004). Redundant mechanisms are used by Ssn6-Tup1 in repressing chromosomal gene transcription in Saccharomyces cerevisiae. J Biol Chem 279, 39240–39250.PubMedGoogle Scholar
  111. Zhao, Y., Wang, S., Popova, E., Grigoryev, S., and Zhu, J. (2009). Rearrangement of Upstream Sequences of the hTERT Gene during Cellular Immortalization. Genes Chromosomes Cancer. In press.Google Scholar
  112. Zhu, J., Wang, H., Bishop, J.M., and Blackburn, E.H. (1999). Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening [see comments]. Proc Natl Acad Sci U S A 96, 3723–3728.PubMedPubMedCentralGoogle Scholar
  113. Zhu, Q., Liu, C., Ge, Z., Fang, X., Zhang, X., Straat, K., Bjorkholm, M., and Xu, D. (2008). Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. PLoS One 3, e1446.PubMedPubMedCentralGoogle Scholar
  114. Zinn, R.L., Pruitt, K., Eguchi, S., Baylin, S.B., and Herman, J.G. (2007). hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67, 194–201.PubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of Cellular and Molecular PhysiologyPennsylvania State University College of MedicineHersheyUSA

Personalised recommendations